Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016095

President and CEO gave up 42,724 shares (to pay taxes)

  • President and CEO acquired 148,714 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-03-02 Option exercise +96,150 1,025,053 D
Walker Neal President and CEO 2020-03-02 Shares withheld for taxes −27,623 $1.26 $34,805 997,430 D
Walker Neal President and CEO 2020-03-02 Option exercise +52,564 1,049,994 D
Walker Neal President and CEO 2020-03-02 Shares withheld for taxes −15,101 $1.26 $19,027 1,034,893 D
Derivatives
Walker Neal President and CEO 2020-03-02 Option exercise · Restricted stock units −96,150 288,450 D
Walker Neal President and CEO 2020-03-02 Grant or award · Employee Stock Option (Right to Buy) +255,552 255,552 D
Walker Neal President and CEO 2020-03-02 Grant or award · Restricted stock units +146,029 146,029 D
Walker Neal President and CEO 2020-03-02 Grant or award · Restricted stock units +73,015 73,015 D
Walker Neal President and CEO 2020-03-02 Grant or award · Restricted stock units +52,564 52,564 D
Walker Neal President and CEO 2020-03-02 Option exercise · Restricted stock units −52,564 0 D
Loading xslF345X03/doc4.xml…